In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 3055-3060

  Rochon Edouard, S ^a   Pestel Caron, M ^a   Lemeland, J F ^a   Caron, F ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOTIAM; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; IMIPENEM; LATAMOXEF; MEROPENEM; NETILMICIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NETILMICIN; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0033744694     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.3055-3060.2000     Document Type: Article

References (38)

1. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response
2. Comparison of ATB Staph, Rapid ATB Staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA
3. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidemidis
4. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
5. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
6. Methicillin-resistant staphylococci
7. Binding of β-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus
8. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin
9. In vitro activity of vancomycin combined with rifampin, amikacin, ciprofloxacin or imipenem against methicillin-resistant and methicillin-susceptible Staphylococcus aureus
10. Report of the comite de l'antibiogramme de la Societe Francaise de Microbiologie
11. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin
12. Antimicrobial combinations
13. Guidelines for the control of methicillin-resistant Staphylococcus aureus
14. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
15. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
16. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
17. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrinplatelet clots in an in vitro infection model
18. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
19. Slow response to vancomycin or vancomycin plus rifampin in methicillin resistant Staphylococcus aureus endocarditis
20. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities
21. Survey of aminoglycoside resistance patterns
22. Vancomycin-gentamicin synergism revisited: Effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus
23. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots
24. Method for reliable determination of minimal lethal antibiotic concentrations
25. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis
26. In vitro interactions between different β-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci
27. Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections
28. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci
29. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus
30. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes
31. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
32. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
33. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics
34. The effect of combinations of cefotiam and other antibiotics on methicillin-resistant Staphylococcus aureus in vitro
35. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo
36. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains
37. The antibacterial activity of meropenem in combination with gentamicin or vancomycin